Screener
Stoke Therapeutics, Inc. STOK Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211874
FAQ
- What is Stoke Therapeutics, Inc.'s enterprise value?
- Stoke Therapeutics, Inc. (STOK) reported enterprise value of $1.77B in Q1 2026.
- How has Stoke Therapeutics, Inc.'s enterprise value changed year-over-year?
- Stoke Therapeutics, Inc.'s enterprise value increased by 1854.5% year-over-year, from $90.75M to $1.77B.
- What is the long-term trend for Stoke Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s enterprise value has grown at a -2.8% compound annual growth rate (CAGR), from $1.99B to $1.73B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Stoke Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude